Clik here to view.
Peer-Reviewed Publication Validates RenovaCare Approach to Rapidly-Processing...
Tuesday, July 11th 2017 at 1:15pm UTC NEW YORK & PITTSBURGH–(BUSINESS WIRE)– RenovaCare, Inc., (OTCQB:RCAR), has announced that its approach to isolating a patient’s own stem cells for subsequent...
View ArticleClik here to view.
Medicrea Reports First Half 2017 Sales
Tuesday, July 11th 2017 at 7:30pm UTC LYON, France & NEW YORK–(BUSINESS WIRE)– The Medicrea Group (Euronext Growth Paris: FR0004178572 – ALMED), pioneering the convergence of healthcare IT and...
View ArticleClik here to view.
Industry Standards Group, Align Biopharma, Expands to 23 Members
Thursday, July 13th 2017 at 11:03am UTC Leading companies join forces to develop and implement new technology standards NEW YORK–(BUSINESS WIRE)– Align BiopharmaTM, a life sciences industry technology...
View ArticleClik here to view.
IMMUNE Pharmaceuticals’ Oncology Subsidiary, CYTOVIA, Announces the Filing of...
Thursday, July 13th 2017 at 11:30am UTC Favorable relapse-free and overall survival in AML patients with persistent leukemic cells NEW YORK–(BUSINESS WIRE)– Cytovia, Inc. (“Cytovia”) the oncology...
View ArticleClik here to view.
FDA Advisory Committee Votes in Favor of Pfizer’s MYLOTARG (gemtuzumab...
Tuesday, July 11th 2017 at 8:32pm UTC Committee votes 6-1 that MYLOTARG in combination with chemotherapy has a favorable risk:benefit profile for patients with newly-diagnosed CD33-positive AML NEW...
View ArticleClik here to view.
Worldwide Clinical Trials Selects Medidata to Streamline Clinical Site...
Wednesday, July 12th 2017 at 12:30pm UTC Medidata’s end-to-end Payments Cloud to help Worldwide change the CRO experience – accelerating accurate, timely payments NEW YORK–(BUSINESS WIRE)– Medidata...
View ArticleClik here to view.
Acorda Second Quarter 2017 Update Webcast/Conference Call Scheduled for July...
Thursday, July 13th 2017 at 11:00am UTC ARDSLEY, N.Y.–(BUSINESS WIRE)– Acorda Therapeutics, Inc. (Nasdaq:ACOR) will host a conference call and webcast to review its second quarter 2017 financial...
View ArticleClik here to view.
Takeda and Schrödinger Announce Multi-Year, Multi-Target Research Collaboration
Thursday, July 20th 2017 at 1:00pm UTC Under novel collaboration approach, Schrödinger will autonomously lead discovery efforts; Takeda provides complementary structural biology support and has option...
View ArticleClik here to view.
DARTS Technology Launches New Drug Target Identification Service Designed to...
Tuesday, July 18th 2017 at 12:30pm UTC Enables Identification of Potential Side Effects Before Trials NEW YORK–(BUSINESS WIRE)– DARTS Sciences, Inc. (www.dartssciences.com) has obtained an exclusive...
View ArticleClik here to view.
Galen Partners and White Oak Healthcare Finance Complete Recapitalization of...
Monday, July 17th 2017 at 12:00pm UTC SUFFERN, N.Y.–(BUSINESS WIRE)– CDx Diagnostics, Inc. (“CDx”) announced today that it has completed a majority recapitalization with Galen Partners, a...
View ArticleClik here to view.
Pfizer Completes License Agreement For The Exclusive Commercialization Rights...
Thursday, July 20th 2017 at 5:23am UTC NEW YORK & BASEL, Switzerland–(BUSINESS WIRE)– Pfizer Inc. (NYSE:PFE)and Basilea Pharmaceutica Ltd. (SIX:BSLN), an international biopharmaceutical company...
View ArticleClik here to view.
BioTime to Host Key Opinion Leader Event on the Topic of Dry AMD in New York...
Tuesday, July 18th 2017 at 11:00am UTC Live Webcast at 12 noon EDT on Tuesday, July 25 ALAMEDA, Calif.–(BUSINESS WIRE)– BioTime, Inc. (NYSE MKT: BTX), a clinical-stage biotechnology company developing...
View ArticleClik here to view.
Klick Health Expands Behavioral Science Team
Tuesday, July 18th 2017 at 2:02pm UTC Agency hires Sociology and Psychology PhDs to expand integrated branding capabilities and further differentiate through innovation TORONTO & NEW...
View ArticleClik here to view.
Cellectis S.A.: Calyxt Announces Pricing of $56.0 Million Initial Public...
Wednesday, July 19th 2017 at 10:51pm UTC ST. PAUL, Minn. & NEW YORK–(BUSINESS WIRE)– Regulatory News: Cellectis S.A. (Paris:ALCLS) (NASDAQ:CLLS) and Calyxt, Inc. announced today the pricing of...
View ArticleClik here to view.
Immune Pharmaceuticals Provides Update on Plan to Implement a Spin-off of...
Wednesday, July 19th 2017 at 1:32pm UTC Immune shareholders to receive additional pro rata shares in Cytovia NEW YORK–(BUSINESS WIRE)– Immune Pharmaceuticals (NASDAQ: IMNP) (“Immune”) today confirmed...
View ArticleClik here to view.
Ophthotech Corporation to Report Second Quarter 2017 Financial Results and...
Friday, July 21st 2017 at 11:30am UTC NEW YORK–(BUSINESS WIRE)– Ophthotech Corporation (Nasdaq:OPHT) today announced that it will report its second quarter 2017 financial and operating results on...
View ArticleClik here to view.
Kadmon Provides Business Update and Reports Second Quarter 2017 Financial...
Thursday, August 3rd 2017 at 8:01pm UTC NEW YORK–(BUSINESS WIRE)– Kadmon Holdings, Inc. (NYSE:KDMN) (“Kadmon” or the “Company”) today provided a business update and reported financial and operational...
View ArticleClik here to view.
FDA Grants Orphan Drug Designation to Kadmon’s Tesevatinib for the Treatment...
Monday, August 7th 2017 at 1:00pm UTC NEW YORK–(BUSINESS WIRE)– Kadmon Holdings, Inc. (NYSE:KDMN) today announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation...
View ArticleClik here to view.
CYTOVIA Inc., IMMUNE Pharma’s Oncology Subsidiary, Announces the Publication...
Monday, August 7th 2017 at 1:27pm UTC Strengthens Intellectual property portfolio and expands potential clinical use and market opportunity NEW YORK–(BUSINESS WIRE)– Cytovia, the oncology subsidiary...
View ArticleClik here to view.
Medidata Earns Recognition as Leading Innovative Company and a Great Place to...
Monday, August 7th 2017 at 12:30pm UTC Medidata is named by Forbes as one of the world’s most innovative companies and listed as a Great Place to Work by FORTUNE. Medidata is the only company in its...
View Article